CEROW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CINGW
Should you be buying CERo Therapeutics stock or one of its competitors? The main competitors of CERo Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.
CERo Therapeutics vs.
180 Life Sciences (NASDAQ:ATNFW) and CERo Therapeutics (NASDAQ:CEROW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, community ranking, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.
180 Life Sciences and CERo Therapeutics both received 0 outperform votes by MarketBeat users.
In the previous week, 180 Life Sciences had 1 more articles in the media than CERo Therapeutics. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for CERo Therapeutics. CERo Therapeutics' average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.24 indicating that CERo Therapeutics is being referred to more favorably in the news media.
Summary
180 Life Sciences and CERo Therapeutics tied by winning 1 of the 2 factors compared between the two stocks.
Get CERo Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CEROW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CEROW vs. The Competition
CERo Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:CEROW) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy CEROW Stock Free CEROW Stock Alerts